Silexion Therapeutics (SLXN) Competitors $3.77 -0.09 (-2.33%) Closing price 04:00 PM EasternExtended Trading$3.76 0.00 (-0.13%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLXN vs. PCSA, ADXN, BCDA, VIVS, APM, RNAZ, CELZ, DWTX, ERNA, and INABShould you be buying Silexion Therapeutics stock or one of its competitors? The main competitors of Silexion Therapeutics include Heatwurx (PCSA), Addex Therapeutics (ADXN), BioCardia (BCDA), VivoSim Labs (VIVS), Aptorum Group (APM), TransCode Therapeutics (RNAZ), Creative Medical Technology (CELZ), Dogwood Therapeutics (DWTX), Ernexa Therapeutics (ERNA), and IN8bio (INAB). These companies are all part of the "pharmaceutical products" industry. Silexion Therapeutics vs. Its Competitors Heatwurx Addex Therapeutics BioCardia VivoSim Labs Aptorum Group TransCode Therapeutics Creative Medical Technology Dogwood Therapeutics Ernexa Therapeutics IN8bio Heatwurx (NASDAQ:PCSA) and Silexion Therapeutics (NASDAQ:SLXN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Is PCSA or SLXN more profitable? Silexion Therapeutics' return on equity of 0.00% beat Heatwurx's return on equity.Company Net Margins Return on Equity Return on Assets HeatwurxN/A -342.36% -243.48% Silexion Therapeutics N/A N/A -355.74% Which has more risk & volatility, PCSA or SLXN? Heatwurx has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Comparatively, Silexion Therapeutics has a beta of 0.04, indicating that its stock price is 96% less volatile than the S&P 500. Do insiders and institutionals hold more shares of PCSA or SLXN? 91.9% of Heatwurx shares are held by institutional investors. Comparatively, 11.0% of Silexion Therapeutics shares are held by institutional investors. 2.4% of Heatwurx shares are held by company insiders. Comparatively, 6.0% of Silexion Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts rate PCSA or SLXN? Heatwurx presently has a consensus target price of $1.00, indicating a potential upside of 418.13%. Silexion Therapeutics has a consensus target price of $75.00, indicating a potential upside of 1,889.39%. Given Silexion Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Silexion Therapeutics is more favorable than Heatwurx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heatwurx 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Silexion Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, PCSA or SLXN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeatwurxN/AN/A-$11.85M-$2.32-0.08Silexion TherapeuticsN/AN/A-$16.44MN/AN/A Does the media prefer PCSA or SLXN? In the previous week, Silexion Therapeutics had 2 more articles in the media than Heatwurx. MarketBeat recorded 3 mentions for Silexion Therapeutics and 1 mentions for Heatwurx. Heatwurx's average media sentiment score of 1.89 beat Silexion Therapeutics' score of 1.30 indicating that Heatwurx is being referred to more favorably in the media. Company Overall Sentiment Heatwurx Very Positive Silexion Therapeutics Positive SummaryHeatwurx and Silexion Therapeutics tied by winning 5 of the 10 factors compared between the two stocks. Get Silexion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLXN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLXN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLXN vs. The Competition Export to ExcelMetricSilexion TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.82M$3.13B$5.75B$10.39BDividend YieldN/A2.39%5.77%4.64%P/E RatioN/A7.5757.3222.37Price / SalesN/A442.69544.74124.93Price / CashN/A44.6737.5461.24Price / Book-0.109.6212.876.30Net Income-$16.44M-$52.73M$3.29B$271.03M7 Day Performance4.43%0.64%-0.26%-0.15%1 Month Performance-47.96%6.31%3.84%6.41%1 Year Performance-95.83%18.97%68.35%28.81% Silexion Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLXNSilexion Therapeutics3.0833 of 5 stars$3.77-2.3%$75.00+1,889.4%-95.6%$2.82MN/A0.00N/ANews CoveragePositive NewsPCSAHeatwurx3.6827 of 5 stars$0.20+0.3%$1.00+397.5%-84.3%$10.12MN/A-0.0920Positive NewsGap DownADXNAddex Therapeutics2.8389 of 5 stars$9.36-2.7%$30.00+220.5%-8.4%$9.92M$170.62K-27.5330Positive NewsUpcoming EarningsBCDABioCardia3.4392 of 5 stars$1.71-20.6%$25.00+1,364.6%-38.6%$9.89MN/A-0.9240News CoveragePositive NewsAnalyst ForecastInsider TradeAnalyst RevisionGap DownHigh Trading VolumeVIVSVivoSim Labs0.7279 of 5 stars$3.78-20.9%N/AN/A$9.83M$140K-0.3720Gap UpAPMAptorum Group0.8284 of 5 stars$1.81-7.7%N/A-12.8%$9.68MN/A0.0030RNAZTransCode Therapeutics2.3489 of 5 stars$11.49+4.9%$280.00+2,337.1%-99.9%$9.45MN/A0.009Positive NewsGap UpCELZCreative Medical Technology1.7543 of 5 stars$3.66+5.0%N/A+0.6%$9.43M$10K-1.155Positive NewsDWTXDogwood Therapeutics2.0029 of 5 stars$4.93+1.2%$10.00+102.8%N/A$9.42MN/A-0.265Positive NewsERNAErnexa Therapeutics1.2203 of 5 stars$1.22+3.4%N/A-93.3%$9.41M$580K-0.1510INABIN8bio3.5336 of 5 stars$2.02+1.0%$180.00+8,810.9%-77.4%$9.26MN/A-0.2220Positive News Related Companies and Tools Related Companies Heatwurx Alternatives Addex Therapeutics Alternatives BioCardia Alternatives VivoSim Labs Alternatives Aptorum Group Alternatives TransCode Therapeutics Alternatives Creative Medical Technology Alternatives Dogwood Therapeutics Alternatives Ernexa Therapeutics Alternatives IN8bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLXN) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silexion Therapeutics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Silexion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
